Development of a quantitative fluorescence lateral flow immunoassay (LFIA) prototype for point-of-need detection of anti-Müllerian hormone

Heather J. Goux, Binh V. Vu, Katherine Wasden, Kannan Alpadi, Ajay Kumar, Bhanu Kalra, Gopal Savjani, Kristen Brosamer, Katerina Kourentzi, Richard C. Willson

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Objective: Anti-Müllerian Hormone (AMH) is a quantitative marker for ovarian reserve and is used to predict response during ovarian stimulation. Streamlining testing to the clinic or even to the physician's office would reduce inconvenience, turnaround time, patient stress and potentially also the total cost of testing, allowing for more frequent monitoring. In this paper, AMH is used as a model biomarker to describe the rational development and optimization of sensitive, quantitative, clinic-based rapid diagnostic tests. Design and Methods: We developed a one-step lateral-flow europium (III) chelate-based fluorescent immunoassay (LFIA) for the detection of AMH on a portable fluorescent reader, optimizing the capture/detection antibodies, running buffer, and reporter conjugates. Results: A panel of commercial calibrators was used to develop a standard curve to determine the analytical sensitivity (LOD = 0.41 ng/ml) and the analytical range (0.41–15.6 ng/ml) of the LFIA. Commercial controls were then tested to perform an initial evaluation of the prototype performance and showed a high degree of precision (Control I CV 2.18%; Control II CV 3.61%) and accuracy (Control I recovery 126%; Control II recovery 103%). Conclusions: This initial evaluation suggests that, in future clinical testing, the AMH LFIA will likely have the capability of distinguishing women with low ovarian reserve (<1 ng/ml AMH) from women with normal (1–4 ng/ml AMH) ovarian reserve. Furthermore, the LFIA demonstrated a wide linear range, indicating the assay's applicability to the detection of other health conditions such as PCOS, which requires AMH measurement at higher concentrations (>6 ng/ml).

Original languageEnglish (US)
Article numbere00314
JournalPractical Laboratory Medicine
StatePublished - May 2023


  • Anti-Müllerian Hormone
  • Antibody
  • Biomarker
  • Europium reporters
  • Fluorescence
  • Lateral flow assay
  • Point-of-need
  • Quantitative

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Clinical Biochemistry


Dive into the research topics of 'Development of a quantitative fluorescence lateral flow immunoassay (LFIA) prototype for point-of-need detection of anti-Müllerian hormone'. Together they form a unique fingerprint.

Cite this